Deadline: 15-Jun-2026
The King Hussein Award for Cancer Research Lifetime Achievement Recognition is a distinguished honor created to recognize exceptional lifetime contributions in oncology and cancer research. It celebrates researchers whose work has fundamentally advanced scientific understanding of cancer and improved patient care. The award highlights both Arab and global scientists who have demonstrated sustained excellence and leadership in the field.
Purpose and Objectives
The primary objective of the award is to honor researchers who have made transformative and lifelong contributions to cancer research. It aims to recognize advances in prevention, diagnosis, treatment, and drug development in oncology. The award also emphasizes strengthening scientific collaboration between Arab institutions and the global research community. It seeks to encourage continued innovation and mentorship in cancer research.
Key Focus Areas
The award focuses on cancer research across multiple dimensions, including biomedical innovation, clinical oncology, translational research, and therapeutic development. It recognizes achievements in drug discovery, treatment protocols, diagnostic improvements, and scientific breakthroughs in cancer biology. Leadership, mentorship, and collaborative research contributions are also key priorities.
Regional and Global Collaboration Focus
A major emphasis of the award is fostering long-term engagement with institutions in the Arab world. It recognizes researchers who actively collaborate with Arab institutions, contribute to capacity building, and support scientific exchange. The award values efforts that strengthen regional healthcare systems and promote sustainable research partnerships.
Scientific Contribution Requirements
Eligible candidates are expected to demonstrate lifelong dedication to cancer research. This includes contributions to prevention strategies, diagnostic innovations, treatment development, and clinical applications. The award also recognizes researchers whose work bridges laboratory science and clinical practice, enabling real-world impact in oncology.
Eligibility Criteria
Eligible nominees must hold an MD, PhD, MD/PhD, or an equivalent qualification. They must be affiliated or have previously been affiliated with a reputable institution involved in cancer research. It is preferred that at least 50% of their career work is dedicated to cancer-related research, reflecting sustained commitment to the field.
Expected Professional Profile
Candidates are expected to be established leaders in oncology research with a strong record of publications and scientific contributions. They should demonstrate innovation in cancer research and a history of impactful discoveries or advancements. Leadership roles in academic, clinical, or research institutions are considered highly relevant.
Nomination Requirements
Nominators must be qualified researchers with a PhD or MD and at least 15 years of active research experience. They must have a strong publication record and be affiliated with recognized academic or medical institutions. This ensures that nominations are made by credible experts with deep knowledge of the field.
Selection Criteria
Selection is based on lifetime achievement in cancer research, scientific impact, and contributions to oncology advancement. Additional considerations include innovation, translational impact, leadership, mentorship, and collaboration with Arab research institutions. The evaluation process prioritizes both regional and global scientific influence.
Award Structure and Recognition
The award is presented annually in Amman, Jordan at a formal ceremony. It includes a monetary prize of USD 30,000. Each year, two recipients are selected—one from the Arab region and one from the international scientific community—ensuring balanced recognition of regional and global contributions.
Importance of the Award
The award plays a significant role in recognizing and promoting excellence in cancer research. It highlights groundbreaking scientific achievements that improve cancer prevention, diagnosis, and treatment. It also strengthens scientific collaboration between Arab countries and the global research community, fostering knowledge exchange and capacity building.
Common Mistakes to Avoid
Nominations may be weakened if candidates lack a clearly demonstrated lifelong commitment to cancer research. Insufficient evidence of impact in oncology or limited publication records can reduce competitiveness. Failure to highlight collaboration with Arab institutions or translational impact may also negatively affect evaluation.
Tips for a Strong Nomination
Strong nominations clearly demonstrate sustained, high-impact contributions to cancer research over an entire career. They should emphasize breakthroughs in oncology, strong publication records, and evidence of leadership and mentorship. Highlighting regional collaboration and real-world clinical impact significantly strengthens the nomination.
Frequently Asked Questions
- What is the King Hussein Award for Cancer Research?
It is a lifetime achievement award recognizing outstanding contributions to cancer research and oncology. - Who is eligible for nomination?
Researchers with MD, PhD, MD/PhD, or equivalent qualifications who have made significant contributions to cancer research. - What is the award value?
The prize is USD 30,000. - How many recipients are selected each year?
Two recipients are selected annually—one regional and one international. - Where is the award presented?
The award ceremony takes place in Amman, Jordan. - Who can nominate candidates?
Qualified researchers with at least 15 years of experience and strong publication records. - What fields are considered?
Cancer research, including prevention, diagnosis, treatment, drug development, and translational oncology.
Conclusion
The King Hussein Award for Cancer Research Lifetime Achievement Recognition is a prestigious global honor that celebrates lifelong excellence in oncology research. It recognizes scientists whose work has transformed cancer prevention, diagnosis, and treatment while strengthening collaboration between Arab and international research communities. By honoring leaders in the field, the award advances scientific progress and inspires continued innovation in the fight against cancer.
For more information, visit King Hussein Cancer Foundation.